149 related articles for article (PubMed ID: 12669455)
1. Antibody-based technologies for target discovery.
Valle RP; Jendoubi M
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):197-203. PubMed ID: 12669455
[TBL] [Abstract][Full Text] [Related]
2. Proteomics technology and therapeutics.
Hong ML; Jiang N; Gopinath S; Chew FT
Clin Exp Pharmacol Physiol; 2006; 33(5-6):563-8. PubMed ID: 16700895
[TBL] [Abstract][Full Text] [Related]
3. High-throughput proteomics using antibody microarrays.
Wingren C; Borrebaeck CA
Expert Rev Proteomics; 2004 Oct; 1(3):355-64. PubMed ID: 15966831
[TBL] [Abstract][Full Text] [Related]
4. Array-based proteomics: the latest chip challenge.
Albala JS
Expert Rev Mol Diagn; 2001 Jul; 1(2):145-52. PubMed ID: 11901809
[TBL] [Abstract][Full Text] [Related]
5. Advances in recombinant antibody microarrays.
Pavlickova P; Schneider EM; Hug H
Clin Chim Acta; 2004 May; 343(1-2):17-35. PubMed ID: 15115675
[TBL] [Abstract][Full Text] [Related]
6. Antibody arrays--an emerging tool in cancer proteomics.
Kopf E; Zharhary D
Int J Biochem Cell Biol; 2007; 39(7-8):1305-17. PubMed ID: 17600752
[TBL] [Abstract][Full Text] [Related]
7. Role and challenges of proteomics in pharma and biotech: technical, scientific and commercial perspective.
Qoronfleh MW
Expert Rev Proteomics; 2006 Apr; 3(2):179-95. PubMed ID: 16608432
[TBL] [Abstract][Full Text] [Related]
8. High-throughput proteomics using antibody microarrays: an update.
Borrebaeck CA; Wingren C
Expert Rev Mol Diagn; 2007 Sep; 7(5):673-86. PubMed ID: 17892372
[TBL] [Abstract][Full Text] [Related]
9. Recombinant antibodies for the generation of antibody arrays.
Borrebaeck CA; Wingren C
Methods Mol Biol; 2011; 785():247-62. PubMed ID: 21901605
[TBL] [Abstract][Full Text] [Related]
10. Activity-based proteomics: enzymatic activity profiling in complex proteomes.
Schmidinger H; Hermetter A; Birner-Gruenberger R
Amino Acids; 2006 Jun; 30(4):333-50. PubMed ID: 16773240
[TBL] [Abstract][Full Text] [Related]
11. Cancer proteomics: Serum diagnostics for tumor marker discovery.
Rai AJ; Chan DW
Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
[TBL] [Abstract][Full Text] [Related]
12. Protein biochips: A new and versatile platform technology for molecular medicine.
Lueking A; Cahill DJ; Müllner S
Drug Discov Today; 2005 Jun; 10(11):789-94. PubMed ID: 15922937
[TBL] [Abstract][Full Text] [Related]
13. Structural mass spectrometry in protein therapeutics discovery.
Kim YJ; Doyle ML
Anal Chem; 2010 Sep; 82(17):7083-9. PubMed ID: 20698501
[TBL] [Abstract][Full Text] [Related]
14. Protein arrays for biomarker discovery.
Reid JD; Parker CE; Borchers CH
Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
[TBL] [Abstract][Full Text] [Related]
15. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography.
Katayama H; Oda Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):21-7. PubMed ID: 17241823
[TBL] [Abstract][Full Text] [Related]
16. Pathway proteomics and chemical proteomics team up in drug discovery.
Hopf C; Bantscheff M; Drewes G
Neurodegener Dis; 2007; 4(2-3):270-80. PubMed ID: 17596721
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Label-free mass spectrometry-based protein quantification technologies in proteomic analysis.
Wang M; You J; Bemis KG; Tegeler TJ; Brown DP
Brief Funct Genomic Proteomic; 2008 Sep; 7(5):329-39. PubMed ID: 18579615
[TBL] [Abstract][Full Text] [Related]
19. Biopharmaceutical drug discovery using novel protein scaffolds.
Gill DS; Damle NK
Curr Opin Biotechnol; 2006 Dec; 17(6):653-8. PubMed ID: 17055245
[TBL] [Abstract][Full Text] [Related]
20. From proteins to proteomics.
Bradshaw RA; Burlingame AL
IUBMB Life; 2005; 57(4-5):267-72. PubMed ID: 16036609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
